These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 21106656)
1. Midregional proatrial natriuretic peptide predicts survival in exacerbations of COPD. Bernasconi M; Tamm M; Bingisser R; Miedinger D; Leuppi J; Müller B; Christ-Crain M; Stolz D Chest; 2011 Jul; 140(1):91-99. PubMed ID: 21106656 [TBL] [Abstract][Full Text] [Related]
2. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563 [TBL] [Abstract][Full Text] [Related]
3. The prognostic value of midregional proatrial natriuretic peptide in patients with hemorrhagic stroke. Fischer M; Katan M; Morgenthaler NG; Seiler M; Müller B; Lackner P; Errath M; Helbok R; Pfausler B; Beer R; Schmutzhard E; Broessner G Cerebrovasc Dis; 2014; 37(2):128-33. PubMed ID: 24481415 [TBL] [Abstract][Full Text] [Related]
4. Plasma pro-adrenomedullin but not plasma pro-endothelin predicts survival in exacerbations of COPD. Stolz D; Christ-Crain M; Morgenthaler NG; Miedinger D; Leuppi J; Müller C; Bingisser R; Struck J; Müller B; Tamm M Chest; 2008 Aug; 134(2):263-272. PubMed ID: 18490402 [TBL] [Abstract][Full Text] [Related]
5. Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study. Khan SQ; Dhillon O; Kelly D; Squire IB; Struck J; Quinn P; Morgenthaler NG; Bergmann A; Davies JE; Ng LL J Am Coll Cardiol; 2008 May; 51(19):1857-64. PubMed ID: 18466800 [TBL] [Abstract][Full Text] [Related]
6. Midregional pro-A-type natriuretic peptide and carboxy-terminal provasopressin may predict prognosis in community-acquired pneumonia. Masiá M; Papassotiriou J; Morgenthaler NG; Hernández I; Shum C; Gutiérrez F Clin Chem; 2007 Dec; 53(12):2193-201. PubMed ID: 17951293 [TBL] [Abstract][Full Text] [Related]
7. MR-pro-atrial natriuretic peptide (MR-proANP) predicts short- and long-term outcomes in respiratory tract infections: a prospective validation study. Vazquez M; Jockers K; Christ-Crain M; Zimmerli W; Müller B; Schuetz P Int J Cardiol; 2012 Apr; 156(1):16-23. PubMed ID: 21093937 [TBL] [Abstract][Full Text] [Related]
8. Circulating levels of pro-atrial natriuretic peptide in lower respiratory tract infections. Müller B; Süess E; Schuetz P; Müller C; Bingisser R; Bergmann A; Stolz D; Tamm M; Morgenthaler NG; Christ-Crain M J Intern Med; 2006 Dec; 260(6):568-76. PubMed ID: 17116008 [TBL] [Abstract][Full Text] [Related]
9. Increased plasma concentrations of midregional proatrial natriuretic Peptide is associated with risk of cardiorenal dysfunction in type 1 diabetes. Theilade S; Hansen TW; Goetze JP; Rossing P Am J Hypertens; 2015 Jun; 28(6):772-9. PubMed ID: 25468806 [TBL] [Abstract][Full Text] [Related]
10. MR-proANP improves prediction of mortality and cardiovascular events in patients with STEMI. Lindberg S; Jensen JS; Pedersen SH; Galatius S; Goetze JP; Mogelvang R Eur J Prev Cardiol; 2015 Jun; 22(6):693-700. PubMed ID: 24906365 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of midregional pro-atrial natriuretic peptide in ventilator-associated pneumonia. Seligman R; Papassotiriou J; Morgenthaler NG; Meisner M; Teixeira PJ Intensive Care Med; 2008 Nov; 34(11):2084-91. PubMed ID: 18523752 [TBL] [Abstract][Full Text] [Related]
12. Pro-atrial natriuretic peptide and pro-vasopressin for predicting short-term and long-term survival in community-acquired pneumonia: results from the German Competence Network CAPNETZ. Krüger S; Ewig S; Kunde J; Hartmann O; Suttorp N; Welte T; Thorax; 2010 Mar; 65(3):208-14. PubMed ID: 20335288 [TBL] [Abstract][Full Text] [Related]
13. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death. Moertl D; Berger R; Struck J; Gleiss A; Hammer A; Morgenthaler NG; Bergmann A; Huelsmann M; Pacher R J Am Coll Cardiol; 2009 May; 53(19):1783-90. PubMed ID: 19422985 [TBL] [Abstract][Full Text] [Related]
14. Adaptive cardiovascular hormones in a spectrum of heart failure phenotypes. Zabarovskaja S; Hage C; Linde C; Daubert JC; Donal E; Gabrielsen A; Mellbin L; Lund LH Int J Cardiol; 2015; 189():6-11. PubMed ID: 25885866 [TBL] [Abstract][Full Text] [Related]
15. Midregional pro-A-type natriuretic peptide for diagnosis and prognosis in patients with suspected acute myocardial infarction. Meune C; Twerenbold R; Drexler B; Balmelli C; Wolf C; Haaf P; Reichlin T; Irfan A; Reiter M; Zellweger C; Meissner J; Stelzig C; Freese M; Capodarve I; Mueller C Am J Cardiol; 2012 Apr; 109(8):1117-23. PubMed ID: 22257708 [TBL] [Abstract][Full Text] [Related]
16. Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: Results from the German Competence Network, CAPNETZ. Krüger S; Ewig S; Giersdorf S; Hartmann O; Suttorp N; Welte T; Am J Respir Crit Care Med; 2010 Dec; 182(11):1426-34. PubMed ID: 20639437 [TBL] [Abstract][Full Text] [Related]
17. The natriuretic peptide MR-proANP predicts all-cause mortality and adverse outcome in community patients: a 10-year follow-up study. Odermatt J; Hersberger L; Bolliger R; Graedel L; Christ-Crain M; Briel M; Bucher HC; Mueller B; Schuetz P Clin Chem Lab Med; 2017 Aug; 55(9):1407-1416. PubMed ID: 28107168 [TBL] [Abstract][Full Text] [Related]
18. Midregional-proAtrial Natriuretic Peptide and High Sensitive Troponin T Strongly Predict Adverse Outcome in Patients Undergoing Percutaneous Repair of Mitral Valve Regurgitation. Wöhrle J; Karakas M; Trepte U; Seeger J; Gonska B; Koenig W; Rottbauer W PLoS One; 2015; 10(9):e0137464. PubMed ID: 26368980 [TBL] [Abstract][Full Text] [Related]
19. Midregional pro-atrial natriuretic peptide and procalcitonin improve survival prediction in VAP. Boeck L; Eggimann P; Smyrnios N; Pargger H; Thakkar N; Siegemund M; Marsch S; Rakic J; Tamm M; Stolz D Eur Respir J; 2011 Mar; 37(3):595-603. PubMed ID: 20530040 [TBL] [Abstract][Full Text] [Related]
20. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease. Elmas E; Brueckmann M; Lang S; Kälsch T; Haghi D; Sueselbeck T; Dempfle CE; Borggrefe M Int J Cardiol; 2008 Aug; 128(2):244-9. PubMed ID: 17673312 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]